Baker Brothers Life Sciences LP, Director, 10% Owner at GENOMIC HEALTH INC (GHDX), sold 49,539 shares at $78.80 ($3.9M) on 2018-11-29, disclosed to the SEC on 2018-12-03.
Open-market sale of $3.9M GHDX by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $77.61 | 801 | $62K | 1.6% |
| 2 | $77.61 | 4,646 | $361K | 9.3% |
| 3 | $77.61 | 30,257 | $2.3M | 60.8% |
| 4 | $78.80 | 1,841 | $145K | 3.8% |
| 5 | $78.80 | 11,994 | $945K | 24.5% |
| Total | $77.94 avg | 49,539 |
| $3.9M |
| 100% |
| Filing → |
| IGMS | BUY | 2023-12-15 | $5.4M | — | Filing → |
| MDGL | BUY | 2023-11-21 | $22.1M | — | Filing → |
| BGNE | SELL | 2023-11-14 | $198.6M | — | Filing → |